Old Web
English
Sign In
Acemap
>
authorDetail
>
Sheldon X. Cao
Sheldon X. Cao
Immunology
Cancer
Protein kinase A
In vivo
PLK1
2
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens
2012
Molecular Cancer Therapeutics
Yuichi Hikichi
Kouhei Honda
Kouki Hikami
Hitoshi Miyashita
Isao Kaieda
Saomi Murai
Noriko Uchiyama
Maki Hasegawa
Tomohiro Kawamoto
Takashi Sato
Takashi Ichikawa
Sheldon X. Cao
Zhe Nie
Lilly Zhang
Johnny Yang
Keisuke Kuida
Erik Kupperman
Show All
Source
Cite
Save
Citations (58)
Composés d'indazole permettant d'activer la glucokinase
2008
Tsuneo Yasuma
Shigekazu Sasaki
Osamu Ujikawa
Yasufumi Miyamoto
Stephen L. Gwaltney
Sheldon X. Cao
Andy Jennings
Show All
Source
Cite
Save
Citations (0)
1